Cti Biopharma reported $23.38M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Applied Genetic Technologies AGTC:US $ 16.42M 2.14M
Baxter International BAX:US $ 2731M 57M
Bristol Myers Squibb BMY:US $ 9.63B 360M
Cti Biopharma CTIC:US $ 23.38M 3.88M
Cytori Therapeutics CYTX:US $ 3.5M 924K
Eli Lilly And LLY:US $ 5296.8M 39.9M
Geron GERN:US $ 25.78M 3.21M
Mirati Therapeutics MRTX:US $ 151.29M 12.89M
Northwest Biotherapeutics NWBO:US 10.4M 2.56M
Novartis NVS:US 10.13B 319M
Novartis NOVN:VX 10.13B 319M
Seattle Genetics SGEN:US $ 722.02M 243.94M
Sunesis Pharmaceuticals SNSS:US $ 14.8M 5.74M
Teva Pharmaceutical Industries TEVA:US 3.26B 64M
YTE INCY:US $ 577.58M 12.7M